Arun Nagarajan

Abstract S1-02: PrECOG 0102: A randomized, double-blind, phase II trial of fulvestrant plus everolimus or placebo in post-menopausal women with hormone receptor (HR)-positive, HER2-negative metastatic breast cancer (MBC) resistant to aromatase inhibitor (AI) therapy

NS Kornblum, Judith Manola, Paula Klein et al. · Cancer Research · 2017 · 35 citations

Medicine, Oncology, Pharmacology +17

Practical and cost-effective model to build and sustain a cardio-oncology program

Diego Sadler, Chakra P. Chaulagain, Beatrice Alvarado et al. · Cardio-Oncology · 2020 · 24 citations · Full text

Medicine, Medical Education, Oncology +13

The Gut Microbiome and Alzheimer’s Disease: A Growing Relationship

Maroun Bou Zerdan, Elsa Hebbo, Ali Hijazi et al. · Current Alzheimer Research · 2022 · 17 citations

Life Sciences, Microbiology, Neuroscience +17

Obesity and overweight are associated with worse survival in early-onset colorectal cancer

Pauline Aeschbacher, Zoe Garoufalia, Justin Dourado et al. · Surgery · 2024 · 15 citations · Full text

Medicine, Oncology, Surgery +17

Total Neoadjuvant Therapy Is a Predictor for Complete Pathological Response in Patients Undergoing Surgery for Rectal Cancer

Nir Horesh, Michael R. Freund, Zoe Garoufalia et al. · Journal of Gastrointestinal Surgery · 2022 · 14 citations · Full text

Medicine, Oncology, Surgery +14